Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis (Q46345823)

21 December 2017

title

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis (English)

1 reference

21 December 2017

0 references

5

Winfried März

1 reference

21 December 2017

6

Christoph Wanner

1 reference

21 December 2017

author name string

Vera Krane

1

1 reference

21 December 2017

Karl Winkler

2

1 reference

21 December 2017

Christiane Drechsler

3

1 reference

21 December 2017

Jürgen Lilienthal

4

1 reference

21 December 2017

German Diabetes and Dialysis Study Investigators

7

1 reference

21 December 2017

language of work or name

English

0 references

publication date

24 September 2008

1 reference

21 December 2017

published in

Kidney International

1 reference

21 December 2017

volume

74

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

1461-1467

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.484

exact match

0 references

cites work

Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Statin use and sepsis events [corrected] in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Prospective study of sudden cardiac death among women in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.484

7 January 2021

Identifiers

DOI

10.1038/KI.2008.484

1 reference

21 December 2017

1 reference

21 December 2017